Mucormycosis and COVID‐19: An epidemic within a pandemic in India
Coronavirus disease (COVID-19) causes an immunosuppressed state and increases risk of secondary infections like mucormycosis. We evaluated clinical features, predisposing factors, diagnosis and outcomes for mucormycosis among patients with COVID-19 infection. This prospective, observational, multi-c...
Saved in:
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Artigo |
Language: | English |
Published: |
2021
|
Online Access: | https://doi.org/10.1111/myc.13353 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|